ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd
宜明昂科
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd
Biotech/Healthcare
Yimingangke is a developer of tumor immunotherapy products, dedicated to the research and development of cancer immunotherapy products, including monoclonal antibodies against immune-regulatory targets and armed, target-specific NK cells.
Latest round: Series C Extension (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.